KRBP insider filings

Kiromic Biopharma, Inc. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-08-26. Screen KRBP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for KRBP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Kiromic Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2024-08-264BERSANI PIETRO — Chief Executive Officer, DirectorPurchase (P): 2,500 @ $2.20 · Purchase (P): 988 @ $1.93EDGAR
2024-08-214Hungerford Brian — Chief Financial OfficerPurchase (P): 258 @ $2.25 · Purchase (P): 3,742 @ $2.20EDGAR
2024-08-144Hungerford Brian — Chief Financial OfficerPurchase (P): 2,000 @ $1.75EDGAR
2024-06-134Misajon Pamela — DirectorPurchase (P): 1,200 @ $3.30 · Purchase (P): 410 @ $3.24EDGAR
2024-06-134Hungerford Brian — CFOPurchase (P): 1,000 @ $2.60EDGAR
2024-06-124Misajon Pamela — DirectorPurchase (P): 1,701 @ $2.93EDGAR
2024-06-124Hungerford Brian — CFOPurchase (P): 1,000 @ $3.18EDGAR
2024-06-124BERSANI PIETRO — CEO, DirectorPurchase (P): 3,000 @ $3.23 · Purchase (P): 3,000 @ $3.28EDGAR
2024-06-124NAGEL MICHAEL — DirectorPurchase (P): 1,000 @ $3.33EDGAR
2024-06-044Ralston Shannon — 10% ownerPurchase (P) @ $2,000,000EDGAR
2024-05-074Hungerford Brian — CFOGrant/award (A): 35,033 @ $0 · Grant/award (A): 21,900 @ $0 · Other (J): 21,900 (derivative) @ $0EDGAR
2024-05-074BERSANI PIETRO — CEO, DirectorGrant/award (A): 45,968 @ $0EDGAR
2024-03-204Catlin Michael — DirectorGrant/award (A): 18,000EDGAR
2024-03-204Misajon Pamela — DirectorGrant/award (A): 18,000EDGAR
2024-03-204NAGEL MICHAEL — DirectorGrant/award (A): 18,000EDGAR
2023-10-064Misajon Pamela — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2023-10-064Catlin Michael — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2023-10-064Hungerford Brian — CFOGrant/award (A): 21,900 (derivative) @ $0EDGAR
2023-10-064BERSANI PIETRO — CEO, DirectorGrant/award (A): 65,600 (derivative) @ $0EDGAR
2023-10-064NAGEL MICHAEL — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-08-154Dahlbeck Scott — Chief of StaffGrant/award (A): 50,000 @ $0EDGAR
2022-08-154Clark Daniel Grant — Chief Financial OfficerGrant/award (A): 50,000 @ $0EDGAR
2022-08-154BERSANI PIETRO — Chief Executive Officer, DirectorGrant/award (A): 638,298 @ $0EDGAR
2022-07-054Cicchetti Americo — DirectorGrant/award (A): 183,600 (derivative) @ $0EDGAR
2022-07-054Tirelli Francis X — DirectorGrant/award (A): 183,600 (derivative) @ $0EDGAR
2022-07-054Reeves Karen — DirectorGrant/award (A): 183,600 (derivative) @ $0EDGAR
2022-07-054NAGEL MICHAEL — DirectorGrant/award (A): 183,600 (derivative) @ $0EDGAR
2022-05-254Dahlbeck Scott — Chief Medical OfficerOption exercise (M): 17,240 · Option exercise (M): 17,240 (derivative) @ $0EDGAR
2021-09-104Chiriva Internati Maurizio — CHIEF EXECUTIVE OFFICER, DirectorPurchase (P): 2,800 @ $3.70EDGAR
2021-08-024Ryan Michael Charles — See RemarksOther (J): 50,189 @ $0 · Other (J): 31,991 (derivative) @ $0EDGAR
2021-06-244Rotino Gianluca — CHIEF STRAT & INNOV OFFICER, DirectorGrant/award (A): 71,985 (derivative) @ $0EDGAR
2021-06-244Nunez Ignacio — CHIEF OPERAT. AND MANUF. OFFI.Grant/award (A): 17,710 (derivative) @ $0 · Grant/award (A): 147,038 (derivative) @ $0EDGAR
2021-05-264Schneider Jerry A. — DirectorPurchase (P): 5,000 @ $7.31EDGAR
2021-03-114/ARotino Gianluca — CSO AND CIO, DirectorDisposition to issuer (D): 4,423 (derivative) @ $0EDGAR
2021-03-114/ATontat Tony — CFO AND COO, DirectorDisposition to issuer (D): 5,528 (derivative) @ $0EDGAR
2021-01-064Tontat Tony — CFO & COO, DirectorGrant/award (A): 5,528 (derivative) @ $0EDGAR
2021-01-064Rotino Gianluca — See Remarks, DirectorGrant/award (A): 4,423 (derivative) @ $0EDGAR

Recent 8-K events — Kiromic Biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-03-218-K1.03 — Bankruptcy or Receivership
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
EDGAR
2025-03-178-K8.01 — Other EventsEDGAR
2025-02-038-K/A1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-038-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-118-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-048-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-09-308-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-058-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-108-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-288-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KRBP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs